Polo-like kinase and its inhibitors: Ready for the match to start?-Reference-Cited by-同舟云学术

Polo-like kinase and its inhibitors: Ready for the match to start?

Published:2015-10-08 Issue:11 Volume:90 Page:1071-1076
ISSN:0361-8609
Container-title:American Journal of Hematology
language:en
Short-container-title:Am. J. Hematol.

Author:

Palmisiano Neil D.¹,Kasner Margaret T.²

Affiliation:

1. Penn State Milton S. Hershey Medical Center; Hershey Pennsylvania

2. Thomas Jefferson University Hospital; Philadelphia Pennsylvania

Publisher

Wiley

Subject

Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/ajh.24177/fullpdf

Reference100 articles.

1. Azacitidine for the treatment of patients with acute myeloid leukemia;Maurillo;Cancer,2012

2. Outcome of patients with myelodysplastic syndrome after failure of decitabine therapy;Jabbour;Cancer,2010

3. Treatment of adult acute lymphoblastic leukemia (ALL) with a focus on emerging investigational and targeted therapies;Mathisen;Oncology (Williston Park),2012

4. polo, a mitotic mutant of Drosophila displaying abnormal spindle poles;Sunkel;J Cell Sci,1988

5. Polo-like kinases: A team that plays throughout mitosis;Glover;Genes Dev,1998

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Design, synthesis, and biological evaluation of novel dihydropteridone derivatives possessing oxadiazoles moiety as potent inhibitors of PLK1;European Journal of Medicinal Chemistry;2023-05

2. PLK1 is a prognostic marker that inhibits immune infiltration in lung adenocarcinoma through necroptosis;2023-02-28

3. PLK1 is a prognostic marker that inhibits immune infiltration in lung adenocarcinoma through necroptosis;2023-01-09

4. 3D-QSAR Studies, Molecular Docking, Molecular Dynamic Simulation, and ADMET Proprieties of Novel Pteridinone Derivatives as PLK1 Inhibitors for the Treatment of Prostate Cancer;Life;2023-01-02

5. PLK1 inhibition-based combination therapies for cancer management;Translational Oncology;2022-02